New chemo combo shows promise for breast cancer patients
NCT ID NCT00433420
First seen May 05, 2026 · Last updated Jun 18, 2026 · Updated 6 times
Summary
This study tested different chemotherapy combinations and schedules for women with breast cancer that had spread to lymph nodes. The goal was to see if adding a drug called fluorouracil or giving chemo every 2 weeks (with a support drug to boost immune recovery) worked better than standard 3-week cycles. About 2,000 women took part, and researchers tracked how long they stayed cancer-free and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.